US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Quasi-New Stocks

588.25

-5.1614-0.87%

Number of Gainers:67

Number of Losers:86

Number of Flat:14

PE:- -

High:602.50

Open:593.41

Low:581.42

Close:593.41

Volume:313.01M

Turnover:8.65B

Market Cap:440.67B

Float Cap:317.68B

Loading ...

Onkure Therapeutics Inc: Expect to File Inds for Each Program in 1H 2027

THOMSON REUTERS

Marqeta to host first-quarter FY2026 results conference call; annual payments volume climbs to nearly $400 billion in FY2025

Senti Biosciences Q4 EPS USD -0.53

THOMSON REUTERS

Senti Biosciences Q4 Revenue USD 22 Thousand

THOMSON REUTERS

OnKure Therapeutics Announces Oversubscribed $150 Million Private Placement to Advance Next-Generation PI3Kα Pan-Mutant Selective Inhibitor Candidates in Breast Cancer and Vascular Anomalies

Press Release: Senti Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides a Corporate Update

Smart Share Global files initial beneficial ownership statement; director Benny Yucong Xu reports no securities beneficially owned

Why Trump's New War Deadline Makes Things Worse for the Stock Market -- Barrons.com

March 2026's Promising Penny Stocks To Watch

Simply Wall St.

How Investors Are Reacting To Procore Technologies (PCOR) Powering NVIDIA’s AI Factory Digital Twin Platform

Simply Wall St.

RenovoRx Inc - Appoints Ramtin Agah as Executive Chairman Effective February 27, 2026 - SEC Filing

THOMSON REUTERS

Werewolf Therapeutics FY2025 net loss narrows 13.76% to $61 million; cash and cash equivalents drop 48.6% to $57 million

RenovoRx appoints Ramtin Agah executive chairman; base salary rises to $450,000

Werewolf Therapeutics Q4 Basic EPS USD -0.17

THOMSON REUTERS

Werewolf Therapeutics Inc - Initiates Process to Explore Strategic Alternatives

THOMSON REUTERS

Press Release: Werewolf Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Updates

BioXcel Therapeutics Reports Fourth Quarter and Full-Year 2025 Financial Results as Company Prepares for Potential IGALMI® Approval in Outpatient Setting

Autolus Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Business Updates

Otsuka to Buy Transcend Therapeutics to Deepen Push Into Next-Generation Psychiatric Drugs

Citi ups Biomea Fusion target, adds ‘upside 90-day catalyst watch’

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BK4539/news?page=14"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4539","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4539\",,,,,undefined,":{"symbol":"BK4539","market":"US","secType":"PLATE","nameCN":"Quasi-New Stocks","latestPrice":588.24677,"timestamp":1774900799999,"preClose":593.40814,"halted":0,"volume":313009390,"delay":0,"changeRate":-0.008698,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Not Yet Opened","change":-5.161377,"latestTime":"03-30 16:00:00 EDT","open":593.40814,"high":602.49536,"low":581.4157,"amount":8649245616.889359,"amplitude":0.035523,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1774963800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":4.896536,"peRate":161.368976,"turnoverRate":0.022215,"increases":67,"decrements":86,"flats":9,"marketCap":440670079570.25,"floatMarketCap":317678481137.875},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4539\",,,,,undefined,":{"symbol":"BK4539","high":602.49536,"amplitude":0.035523,"preClose":593.40814,"low":581.4157,"pbRate":"4.896536","latestPrice":588.24677,"volume":313009390,"delay":0,"open":593.40814,"prevYearClose":881.5255,"prevWeekClose":593.4081,"prevMonthClose":663.4647,"prevQuarterClose":881.5255,"fiveDayClose":668.3832,"twentyDayClose":673.9109,"sixtyDayClose":881.5255,"secType":"PLATE","market":"US","turnoverRate":0.022215,"peRate":161.368976,"marketCap":440670079570.25,"floatMarketCap":317678481137.875,"timestamp":1774900799999,"nameCN":"Quasi-New Stocks"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4539\",,,,undefined,":{"bkCode":"BK4539","up":67,"down":86,"flat":14},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4539\",pageSize:20,pageCount:14,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2622262598","title":"Onkure Therapeutics Inc: Expect to File Inds for Each Program in 1H 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2622262598","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622262598?lang=en_us&edition=fundamental","pubTime":"2026-03-27 20:00","pubTimestamp":1774612841,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260327:nFWN40F0P3:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4539","OKUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622082615","title":"Marqeta to host first-quarter FY2026 results conference call; annual payments volume climbs to nearly $400 billion in FY2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2622082615","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622082615?lang=en_us&edition=fundamental","pubTime":"2026-03-27 20:00","pubTimestamp":1774612818,"startTime":"0","endTime":"0","summary":"Marqeta will host a conference call and webcast on May 5, 2026 at 4:30 pm ET to discuss first quarter 2026 financial results.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Marqeta Inc. published the original content used to generate this news brief via Business Wire  on March 27, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260327:nNDL5MSb4D:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4561","BK4106","MQ","BK4551","BK4535","BK4539","BK4227"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622826184","title":"Senti Biosciences Q4 EPS USD -0.53","url":"https://stock-news.laohu8.com/highlight/detail?id=2622826184","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622826184?lang=en_us&edition=fundamental","pubTime":"2026-03-27 20:00","pubTimestamp":1774612801,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260327:nPLX314FBF:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","BK4139","SNTI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622826183","title":"Senti Biosciences Q4 Revenue USD 22 Thousand","url":"https://stock-news.laohu8.com/highlight/detail?id=2622826183","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622826183?lang=en_us&edition=fundamental","pubTime":"2026-03-27 20:00","pubTimestamp":1774612801,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260327:nPLX314FBF:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4539","SNTI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622282604","title":"OnKure Therapeutics Announces Oversubscribed $150 Million Private Placement to Advance Next-Generation PI3Kα Pan-Mutant Selective Inhibitor Candidates in Breast Cancer and Vascular Anomalies","url":"https://stock-news.laohu8.com/highlight/detail?id=2622282604","media":"GlobeNewswire","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622282604?lang=en_us&edition=fundamental","pubTime":"2026-03-27 20:00","pubTimestamp":1774612800,"startTime":"0","endTime":"0","summary":"-- Financing led by Access Biotechnology with participation from new and existing investors -- Financing to support advancement of two next-generation PI3Kα pan-mutant inhibitors for breast cancer and","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/03/27/3263729/0/en/OnKure-Therapeutics-Announces-Oversubscribed-150-Million-Private-Placement-to-Advance-Next-Generation-PI3K%CE%B1-Pan-Mutant-Selective-Inhibitor-Candidates-in-Breast-Cancer-and-Vascular-.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","IND","BK4539","LENZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622149826","title":"Press Release: Senti Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides a Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2622149826","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622149826?lang=en_us&edition=fundamental","pubTime":"2026-03-27 20:00","pubTimestamp":1774612800,"startTime":"0","endTime":"0","summary":"\"2025 was a year of important progress for Senti as we continued to advance our mission of developing next-generation cell and gene therapies powered by our synthetic biology platform. Over the past year, we have strengthened the clinical and translational foundation of our pipeline, with SENTI-202 as the lead program generating positive clinical data, while continuing to refine and expand the capabilities of our Gene Circuit platform. We remain focused on disciplined execution, advancing our key programs toward critical development milestones and positioning Senti to deliver smarter, more selective medicines for patients with serious diseases. I am proud of our team's commitment and believe the progress we made in 2025 positions us well for the opportunities ahead,\" commented Timothy Lu, MD, PhD, Co-Founder and CEO of Senti Biosciences.-- Reported updated positive preliminary clinical data from the ongoing. , demonstrating encouraging response rates, durability, and a. -- Received Reg","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4539","SNTI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622825880","title":"Smart Share Global files initial beneficial ownership statement; director Benny Yucong Xu reports no securities beneficially owned","url":"https://stock-news.laohu8.com/highlight/detail?id=2622825880","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622825880?lang=en_us&edition=fundamental","pubTime":"2026-03-27 19:22","pubTimestamp":1774610521,"startTime":"0","endTime":"0","summary":"Smart Share Global files initial beneficial ownership statement; director Benny Yucong Xu reports no securities beneficially owned. Smart Share said director Benny Yucong Xu filed an initial Form 3 statement of beneficial ownership.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Smart Share Global Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 27, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260327:nNDL4YDrG7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EM","BK4505","BK4539","BK4076"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622112823","title":"Why Trump's New War Deadline Makes Things Worse for the Stock Market -- Barrons.com","url":"https://stock-news.laohu8.com/highlight/detail?id=2622112823","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622112823?lang=en_us&edition=fundamental","pubTime":"2026-03-27 19:09","pubTimestamp":1774609740,"startTime":"0","endTime":"0","summary":"The market may finally be waking up to the damaging reality of the Iran war.The stock market having its worst day of the conflict a month into the fighting is a bad sign. The S&P 500 fell 1.7%, while the Nasdaq Composite tumbled 2.4% Thursday -- both closing at around six-month lows. The latter entered correction territory, albeit partly due to Meta's sharp drop.But what's more worrying is the muted reaction to President Donald Trump postponing strikes on Iranian energy facilities for another 10 days. It may be down to reports that the Pentagon is looking at sending up to 10,000 additional troops to the Middle East.If the pause holds and there's no resolution, it means 10 more days of low traffic through the Strait of Hormuz, elevated energy prices, and more uncertainty. Deadlines also spark volatility -- yesterday's trading ahead of Trump's original Friday cut-off is a stark reminder.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0158827781.USD","LU0943347566.SGD","LU1778281490.HKD","LU0456855351.SGD","LU1989764664.SGD","SG9999004303.SGD","LU0965509010.AUD","SG9999014542.SGD","SG9999015358.SGD","LU1066051811.HKD","BK4559","IE0005OL40V9.USD","LU2191332357.HKD","LU2237443978.SGD","LU2265009873.SGD","LU1066053197.SGD","LU1814569148.SGD","LU1674673428.USD","LU2168564222.USD","LU1366333091.USD","LU0109391861.USD","LU2362540622.SGD","LU2543165471.USD","IE00B4YYXB79.USD","IE000ITXATA3.USD","LU0077335932.USD","LU2087625088.SGD","LU0444971666.USD","LU0096362180.USD","BK4566","SG9999002224.SGD","LU2028103732.USD","LU0823434583.USD","LU1815336760.USD","NFXL","IE00BFSS7M15.SGD","LU2237957811.SGD","SG9999001424.SGD","LU2471134952.CNY","IE00B19Z8W00.USD","SG9999015341.SGD","IE00BQXX3D17.EUR","IE00B4JS1V06.HKD","LU1280957306.USD","SG9999002232.USD","LU0314106906.USD","LU0417517546.SGD","LU2065169927.USD","LU1244550494.USD","LU1720051017.SGD","LU0889565833.HKD","LU0957791311.USD","APLY","LU0823434740.USD","SGXZ31699556.SGD","LU0320765059.SGD","BK4588","AAPD","LU0234570918.USD","LU2237443895.HKD","LU0354030511.USD","LU0265550946.USD","LU2125154778.USD","LU1116320901.HKD","NFLW","IE00BLSP4239.USD","LU0345769631.USD","LU1989771016.USD","LU0820561909.HKD","IE0009356076.USD","LU1629891620.HKD","LU0170899867.USD","IE00BZ1G4Q59.USD","LU0267386448.USD","LU2089283258.USD","LU2458330169.SGD","LU0949170772.SGD","LU0256863902.USD","LU1206712785.SGD","LU1582986433.USD","LU1496350171.SGD","LU1718418525.SGD","LU0289961442.SGD","LU2111349929.HKD","LU0203202063.USD","LU0225283273.USD","LU1803068979.SGD","LU2896262040.SGD","LU0072462426.USD","LU1244550221.USD","LU0545039389.USD","LU0784385170.HKD","BK4571","HK0000914660.USD","LU0965508806.USD","LU1699723380.USD","LU0069063385.USD","LU1496350502.SGD","LU1935042991.SGD","LU2420271590.USD","LU0308772762.SGD","LU2746668461.USD","LU2083900584.USD","HK0000320223.HKD","LU2247934214.USD","IE0004445239.USD","LU2417539215.USD","IE00BFSS8Q28.SGD","LU0081259029.USD","LU1914381329.SGD","LU0942090050.USD","LU1582987597.SGD","LU2746668974.SGD","LU1206713676.USD","IE0004086264.USD","LU1989772923.USD","SGXZ51526630.SGD","LU2430703178.SGD","LU1934455863.HKD","SGXZ99366536.SGD","LU1235294995.USD","LU2505996681.GBP","LU0323591593.USD","IE00BDCRKT87.USD","IE00BQXX3F31.USD","LU2054465674.USD","LU0251132253.USD","BK4548","HK0000306685.HKD","LU0109392836.USD","LU2108987350.USD","LU0265550359.USD","MACW.SI","LU1582987324.SGD","BK4553","LU1732799900.SGD","IE0004091025.USD","LU2347655156.SGD","BK4108","LU0882574139.USD","LU0354030438.USD","LU0053666078.USD","LU0345770993.USD","LU2237443465.HKD","LU2077746001.SGD","LU1232071149.USD","LU1506573853.SGD","LU2133065610.SGD","LU0553294199.USD","LU0210536198.USD","LU2237443549.SGD","LU2326559502.SGD","IE00BJTD4V19.USD","AAPW","LU2092937148.SGD","LU2552382215.SGD","LU1571399168.USD","LU1935042215.USD","IE0034235303.USD","LU2487616109.SGD","LU0823421333.USD","LU0724617625.USD","LU1823568750.SGD","LU0345768740.USD","LU2089284900.SGD","LU2381873111.SGD","LU0353189680.USD","LU2430703251.USD","SG9999015986.USD","IE0009G5SDU7.USD","LU1069344957.HKD","LU0683600562.USD","LU2023250330.USD","IE00BKPKM429.USD","LU0979878070.USD","BK4507","LU0444973449.USD","LU2264538146.SGD","BK4527","LU0345768153.USD","HK0000914686.HKD","SG9999015978.USD","LU1084165304.USD","LU1582986359.USD","LU2087621335.USD","BK4575","LU1301847155.USD","LU2237438978.USD","BK4023","LU0314104364.USD","IE00BJTD4N35.SGD","LU2213496289.HKD","LU1868837300.USD","LU2452424414.USD","LU2023250504.SGD","HK0000320264.USD","LU0210533765.USD","LU2462157665.USD","LU0061475181.USD","LU0787776722.HKD","LU1804176565.USD","LU0234572021.USD","LU1917777945.USD","LU2362541513.USD","LU0082616367.USD","IE00BJJMRX11.SGD","LU2430703095.HKD","LU2458330243.SGD","LU2097344431.USD","LU2065170008.USD","LU1267930730.SGD","LU1791710400.SGD","AAPB","IE00BN29S564.USD","SG9999014559.SGD","IE00BQXX3C00.GBP","BK4581","SG9999018865.SGD","IE00B775SV38.USD","LU1989764748.USD","LU2360106780.USD","LU2860962120.EUR","LU0157215616.USD","LU1935042488.USD","LU2361044949.HKD","LU0672654240.SGD","GB00BDT5M118.USD","BK4170","LU0861579265.USD","LU2756315664.SGD","LU0912757837.SGD","SG9999014898.SGD","LU0079474960.USD","BK4550","AAPU","LU0689626769.HKD","LU0511384066.AUD","LU2552382132.HKD","LU2347655073.USD","LU2461242641.AUD","LU2242650005.HKD","LU0823421416.USD","NFLU","LU1935043023.USD","LU2242649171.HKD","LU0642271901.SGD","LU0820561818.USD","LU1548497426.USD","IE00B775H168.HKD","LU0965509283.SGD","LU2250418816.HKD","DJT","LU1242518931.SGD","LU0528227936.USD","LU0868494708.USD","LU0198837287.USD","BK4576","LU1720051108.HKD","LU1064131342.USD","LU1261432733.SGD","BK4539","LU2756315318.SGD","LU1244550577.SGD","IE00BJJMRY28.SGD","SG9999014914.USD","LU1868836914.USD","BK4533","LU1934455277.USD","LU1868836757.USD","LU2168563687.JPY","BK4505","LU1551013425.SGD","LU0786609619.USD","LU1066051225.USD","LU2403377893.USD","LU2471134879.HKD","LU1429558221.USD","LU0965509101.SGD","LU1366192091.USD","BK4532","BK4573","IE00BJLML261.HKD","LU1551013342.USD","LU1003077747.HKD","LU2361045086.USD","LU0708995401.HKD","LU0057025933.USD","BK4598","LU0949170426.SGD","LU0719512351.SGD","BK4551","IE00B5949003.HKD","AAPY","LU1066051498.USD","LU2552382058.USD","SG9999018857.SGD","LU0106261372.USD","LU1316542783.SGD","LU2125154935.USD","IE00BLSP4452.SGD","LU1674673691.USD","LU1145028129.USD","SG9999015945.SGD","IE00B19Z9505.USD","LU2286300806.USD","SG9999015952.SGD","LU0203201768.USD","LU0154236417.USD","BK4554","BK4534","LU2602419157.SGD","SG9999000418.SGD","IE00BN8TJ469.HKD","LU0056508442.USD","LU2065171311.SGD","IE00BKDWB100.SGD","IE00BK4W5L77.USD","LU1852331112.SGD","LU0661504455.SGD","LU2237443622.USD","LU2357305700.SGD","NFXS","SGXZ23171101.USD","LU2456880835.USD","BK4512","LU2092627202.USD","LU0124676726.USD","LU1642822529.SGD","LU0784383803.USD","IE0004445015.USD","LU1046421795.USD","LU1116320737.USD","LU0149725797.USD","LU0738911758.USD","LU2023250843.SGD","LU1868836591.USD","LU0061474960.USD","LU2023251221.USD","IE00B3SWFQ91.USD","LU2237957902.USD","LU0289739343.SGD","LU0726765562.USD","LU2362541273.HKD","LU1934455194.USD","LU1868837136.USD","SG9999014880.SGD","LU1935043536.SGD","LU1791710582.SGD","LU0348723411.USD","LU1035775433.USD","LU2063271972.USD","LU2106854487.HKD","LU0466842654.USD","BK4022","LU0957808578.USD","LU1127390331.HKD","LU0345770308.USD","LU2361044865.SGD","BK4524","LU0795875169.SGD","BK4515","HK0000306701.USD","LU0868494617.USD","IE000YTNTUN2.SGD","LU0006306889.USD","LU0820562030.AUD","BK4585","IE00B3S45H60.SGD","LU2750360641.GBP","LU2750360997.AUD","LU0353189763.USD","LU0784385840.USD","LU0788109477.HKD","IE0001KFT4U8.USD","IE00B7KXQ091.USD","LU0316494557.USD","IE00BBT3K403.USD","LU1119994496.HKD","LU0096364046.USD","BK4230","LU2360032135.SGD","LU0097036916.USD","LU2271345857.HKD","NFLY","SG9999014906.USD","LU2236285917.USD","SG9999014567.USD","LU0215105999.USD","LU0210528500.USD","LU0048584097.USD","LU1815333072.USD","LU2592432038.USD","IE00BYXW3230.USD","LU0256863811.USD","IE000KEQY171.SGD","LU1037948541.HKD","LU0640476718.USD","LU1989772840.SGD","IE00B19Z8X17.USD","BK4501","IE0003U64NQ7.SGD","BK4574","LU0070217475.USD","LU1242518857.USD","LU2168564495.EUR","IE00B1XK9C88.USD","LU0784384876.USD","LU2471134523.USD","LU0158827948.USD","LU1037948897.HKD","LU0985320562.USD","BK4592","LU1974910355.USD","IE00BK4W5M84.HKD","IE00B1BXHZ80.USD","LU2168564065.EUR","LU2471134796.USD","IE000W1ABFV2.USD","NFLP","LU0127658192.USD","BK4579","LU0494093205.USD","AAPX","SG9999017495.SGD","SG9999014575.USD","LU0080751232.USD","LU0795875086.SGD","SGXZ81514606.USD","LU0345769128.USD","LU0472753341.HKD","LU2097344357.USD","LU2065171402.SGD","LU2505996509.AUD","LU2237443382.USD","LU2168564149.EUR","BK4587","IE00BKVL7J92.USD","LU1988902786.USD","LU1732800096.USD","LU1291159041.SGD","IE00BDRTCR15.USD","IE0034235295.USD","LU0689472784.USD","LU1839511570.USD","IE00BWXC8680.SGD","LU0011850046.USD","LU0476273544.USD","LU1435385759.SGD","IE00BSNM7G36.USD","LU0238689110.USD","LU0964807845.USD"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2622232878","title":"March 2026's Promising Penny Stocks To Watch","url":"https://stock-news.laohu8.com/highlight/detail?id=2622232878","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622232878?lang=en_us&edition=fundamental","pubTime":"2026-03-27 19:05","pubTimestamp":1774609510,"startTime":"0","endTime":"0","summary":"Over the last 7 days, the market has dropped 1.6%, but it remains up by 15% over the past year, with earnings expected to grow by 16% annually. In such a climate, identifying stocks with solid financial health can be crucial for investors looking for growth opportunities. Penny stocks—often associated with smaller or newer companies—still hold potential when they demonstrate financial strength and long-term promise.","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-nuvb/nuvation-bio/news/march-2026s-promising-penny-stocks-to-watch","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-nuvb/nuvation-bio/news/march-2026s-promising-penny-stocks-to-watch","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU2362541273.HKD","SG9999006266.SGD","LU1242518857.USD","BK4230","LU1839390173.USD","SGXZ58947870.SGD","SIGA","BK4122","LU0441851309.USD","BK4076","LU0532188223.SGD","BK4183","LU2362540622.SGD","LU2125910500.SGD","BK4142","LU2045819591.USD","TOUR","BK4503","BK4007","GRAB","BK4125","LU1242518931.SGD","LFVN","NAGE","LU0979878070.USD","LU2362541513.USD","LU1046422090.SGD","SG9999002620.SGD","BK4531","BK4579","LU0049112450.USD","NUVB","SG9999001135.SGD","SG9999002406.SGD","SG9999013486.USD","LU1235295612.USD","BK4191","BK4134","BK4583","III","RERE","CRCT","SG9999013478.USD",".IXIC","SG9999002604.SGD","SG9999002414.USD","BK4022","FINV","BK4166","BK4539","SSP","LX","BK4121","SG9999013460.SGD","SG9999002679.SGD","LU0210637038.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622082325","title":"How Investors Are Reacting To Procore Technologies (PCOR) Powering NVIDIA’s AI Factory Digital Twin Platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2622082325","media":"Simply Wall St.","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622082325?lang=en_us&edition=fundamental","pubTime":"2026-03-27 19:04","pubTimestamp":1774609497,"startTime":"0","endTime":"0","summary":"In March 2026, Procore Technologies announced it had integrated its construction management platform with NVIDIA Omniverse DSX Blueprint to create real-time digital twins, unify data from more than 15 BIM and CAD formats, and support safer, more efficient delivery of AI factories and other complex infrastructure.\nAn important angle for investors is that NVIDIA is using Procore’s continuous digital thread to build its own AI factories, potentially reinforcing Procore’s role as a core software...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/8041000-choice2-main-header/1585186556238","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/8041000-choice2-main-header/1585186556238"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/software/nyse-pcor/procore-technologies/news/how-investors-are-reacting-to-procore-technologies-pcor-powe","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/software/nyse-pcor/procore-technologies/news/how-investors-are-reacting-to-procore-technologies-pcor-powe","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU2326559502.SGD","SG9999015952.SGD","LU2433249047.HKD","LU0127658192.USD","LU1261432733.SGD","LU1202635105.USD","LU2242649171.HKD","LU0683600562.USD","LU0353189680.USD","LU1934455194.USD","LU2931357623.SGD","LU1232071149.USD","LU2271345857.HKD","LU1935042991.SGD","LU2491050154.USD","LU1821325948.USD","LU2125909247.SGD","LU0957791311.USD","LU2054465674.USD","LU0868494617.USD","BK4581","IE00BJTD4N35.SGD","LU0965509010.AUD","LU2322448957.HKD","IE00BN29S564.USD","NVDY","SG9999018857.SGD","LU2264538146.SGD","LU2125154935.USD","LU0079474960.USD","NVD","LU2463028550.USD","3NVD.UK","LU0310800379.SGD","LU1721428933.USD","LU0234572021.USD","LU0215105999.USD","LU0786609619.USD","LU1244550577.SGD","LU2106854487.HKD","IE00BMPRXQ63.HKD","SG9999015341.SGD","LU0354030511.USD","LU2360106780.USD","LU2065169927.USD","LU0861579265.USD","IE0001KFT4U8.USD","LU1914381329.SGD","LU2458330169.SGD","LU0511384066.AUD","LU1720051108.HKD","HK0000320223.HKD","LU0965508806.USD","LU1366192091.USD","HK0000914686.HKD","LU1720051017.SGD","LU2471134879.HKD","IE0034235188.USD","BK4529","ANV","LU0210533765.USD","LU2746668461.USD","IE00BQXX3F31.USD","LU0238689110.USD","LU1923622614.USD","BK4612","LU0265550359.USD","LU1868836914.USD","LU1815333072.USD","LU2028103732.USD","LU0157215616.USD","LU0345768153.USD","SG9999001424.SGD","LU2265009873.SGD","BK4585","LU0316494557.USD","LU2083900584.USD","LU2361044949.HKD","LU0390134368.USD","LU0265550946.USD","LU0072462426.USD","LU2168564065.EUR","NVDX","IE00BK4W5M84.HKD","LU0175139822.USD","NVD2.UK","LU1116320901.HKD","LU1935042215.USD","LU2322448791.USD","LU0082616367.USD","IE0034235295.USD","SGXZ23171101.USD","SG9999015978.USD","LU2272731865.HKD","LU2097344431.USD","LU2250418816.HKD","LU1935043023.USD","LU1066051811.HKD","LU1989764748.USD","LU2065171402.SGD","SNVD.UK","HK0000914660.USD","IE00BZ199S13.USD","LU0006306889.USD","LU0096364046.USD","LU1642822529.SGD","LU1571399168.USD","LU1127390331.HKD","LU0289960550.SGD","LU1153585028.USD","LU2750360641.GBP","LU2065170008.USD","LU1242518931.SGD","LU0266013472.USD","NVDU","LU2272731782.SGD","LU1633808545.USD","LU0081259029.USD","IE00B4JS1V06.HKD","SG9999014898.SGD","LU0942090050.USD","LU2491050071.SGD","LU0210536198.USD","IE00BZ1G4Q59.USD","LU0724617625.USD","LU0672654240.SGD","BK4548","LU0354030438.USD","LU2191332357.HKD","IE0034235303.USD","IE000KEQY171.SGD","LU2211815571.USD","SGXZ81514606.USD","SG9999014575.USD","LU0310799852.SGD","IE00BMPRXN33.USD","LU1244550494.USD","IE00B5949003.HKD","HK0000304797.USD","LU0642271901.SGD","LU2543165471.USD","IE00BD6J9T35.USD","LU0889565833.HKD","NVDS.UK","LU1712237335.SGD","IE00B19Z8W00.USD","HK0000306701.USD","LU2471134952.CNY","LU2552382132.HKD","LU2023251221.USD","LU1366333091.USD","LU0965509283.SGD","LU1244550221.USD","NVDW","LU1804176565.USD","LU1861127337.USD","LU2430703095.HKD","IE0009G5SDU7.USD","IE00B1BXHZ80.USD","NVIW.SI","LU1934455277.USD","LU0070217475.USD","LU2237957902.USD","LU0965509101.SGD","LU1852331112.SGD","IE00BJLML261.HKD","LU2168564149.EUR","LU0057025933.USD","LU0097036916.USD","LU2456880835.USD","LU0094547139.USD","LU0011850046.USD","LU0251132253.USD","LU2089284900.SGD","LU2506951792.HKD","LU0347712357.USD","LU2552382058.USD","LU2552382215.SGD","LU2247934214.USD","IE00B3M56506.USD","LU2092627202.USD","LU1280957306.USD","LU2087621335.USD","NVD3.UK","IE00BJJMRX11.SGD","SG9999018865.SGD","LU1951198990.SGD","LU2471134523.USD","LU1992135399.USD","LU2087625088.SGD","LU1400636574.HKD","BK4579","LU0128525929.USD","LU0823414478.USD","LU2168563687.JPY","LU0823414551.USD","SG9999014542.SGD","LU0289739343.SGD","LU0170899867.USD","IE00BKDWB100.SGD","LU2487616109.SGD","LU0056508442.USD","LU0708995401.HKD","LU2361045086.USD","LU2417539215.USD","BK4527","LU1868837136.USD","IE0005OL40V9.USD","LU0048584097.USD","LU1861215975.USD","BK4608","LU2452424414.USD","IE00BFSS8Q28.SGD","LU0080751232.USD","LU1435385759.SGD","IE00BWXC8680.SGD","LU0345768740.USD","LU0348723411.USD","LU0985320562.USD","IE000YTNTUN2.SGD","LU2063271972.USD","SG9999002224.SGD","BK4605","LU1718418525.SGD","BK4550","LU0476273544.USD","LU2458330243.SGD","LU2023250330.USD","LU2357125470.USD","IE0009356076.USD","LU1815336760.USD","LU2381873111.SGD","LU0061475181.USD","BK4533","LU1778281490.HKD","LU0109391861.USD","LU1119994496.HKD","LU0342679015.USD","LU0203202063.USD","LU1861220033.SGD","LU1674673691.USD","BK4588","LU0444973449.USD","LU0069063385.USD","LU1323610961.USD","IE00BK4W5L77.USD","LU0708994859.HKD","NVDS","LU0943347566.SGD","LU2360107168.USD","IE0004086264.USD","LU0234570918.USD","LU2750360997.AUD","LU1923622291.USD","LU0788109477.HKD","PCOR","NVDD","IE0004091025.USD","LU1839511570.USD","LU2125909916.SGD","LU0820562030.AUD","BK4598","LU0466842654.USD","LU2471134796.USD","LU1037948897.HKD","SG9999014559.SGD","IE00B1XK9C88.USD","LU1066051498.USD","LU2413666699.HKD","HK0000306685.HKD","IE000W1ABFV2.USD","LU0417517546.SGD","LU0787776722.HKD","LU1691799644.USD","LU2360032135.SGD","IE00B19Z9505.USD","LU0203201768.USD","2NVD.UK","LU0276348264.USD","BK4141","LU0029864427.USD","LU2272731600.USD","BK4549","LU0210528500.USD","LU2236285917.USD","LU1496350502.SGD","LU2420271590.USD","LU0345770308.USD","IE00BKVL7J92.USD","LU2505996681.GBP","LU1923623000.USD","LU2403377893.USD","SG9999000418.SGD","LU1814569148.SGD","NVDG","LU1951200564.SGD","LU2294711713.HKD","LU1989764664.SGD","SG9999014567.USD","LU0689472784.USD","LU2023250504.SGD","LU2461242641.AUD","LU2097344357.USD","LU2357305700.SGD","LU2089985449.USD","LU1429558221.USD","LU1623119135.USD","SG9999014914.USD","IE00BDRTCR15.USD","LU0053666078.USD","LU1935043536.SGD","LU0211327993.USD","BK4551","IE00BQXX3D17.EUR","LU1267930490.SGD","SG9999004303.SGD","LU1803068979.SGD","LU2505996509.AUD","SGXZ31699556.SGD","IE00BYXW3230.USD","IE0003U64NQ7.SGD","LU0323591593.USD","LU0096362180.USD","LU1935042488.USD","LU1988902786.USD","LU1629891620.HKD","LU1699723380.USD","LU1670756490.USD","LU1316542783.SGD","BK4592","LU2077746001.SGD","BK4023","LU2860962120.EUR","LU0225283273.USD","LU1934455863.HKD","LU0077335932.USD","LU0198837287.USD","LU2290526834.HKD","IE00BKPKM429.USD","SG9999015358.SGD","LU0964807845.USD","NVDQ","LU0211328371.USD","LU2237957811.SGD","LU0444971666.USD","LU1868836757.USD","SG9999002232.USD","SG9999015986.USD","BK4614","LU1496350171.SGD","LU0640476718.USD","SG9999017495.SGD","IE00BQXX3C00.GBP","LU0158827781.USD","LU2125154778.USD","LU1066053197.SGD","NVDB","HK0000304805.HKD","LU0823434740.USD","LU1116320737.USD","SG9999014880.SGD","IE00B3S45H60.SGD","LU0823421333.USD","IE00BMPRXR70.SGD","LU2462157665.USD","LU2244417387.USD","LU1069344957.HKD","LU1989772840.SGD","LU1400636491.USD","LU0719512351.SGD","LU0882574139.USD","LU1066051225.USD","LU2430703178.SGD","DIPS","LU1037948541.HKD","LU2168564222.USD","LU1064131342.USD","LU2092937148.SGD","IE0004445015.USD","LU2065171311.SGD","NVII","LU0868494708.USD","LU1548497426.USD","LU1791710400.SGD","LU0957808578.USD","LU0528227936.USD","LU1267930573.SGD","LU2361044865.SGD","LU2473716301.USD","LU1989772923.USD","IE000ITXATA3.USD","LU0154236417.USD","LU1868836591.USD","LU2286300806.USD","IE00BDCRKT87.USD","HK0000320264.USD","LU0107464264.USD","LU0345769631.USD","LU1645745479.HKD","IE00B775SV38.USD","LU0187121727.USD","LU1145028129.USD","LU1917777945.USD","BK4554","SGXZ51526630.SGD","SG9999015945.SGD","LU0061474960.USD","LU1992135472.HKD","LU2242650005.HKD","IE00BJJMRY28.SGD","LU2491049909.HKD","GB00BDT5M118.USD","LU2413666426.HKD","SG9999014906.USD","LU2089283258.USD","BK4535","LU2746668974.SGD","LU1551013342.USD","LU1791710582.SGD","LU0979878070.USD","LU0274383776.USD","IE00B3SWFQ91.USD","LU0106261372.USD","LU0256863811.USD","LU0353189763.USD","LU2125909593.SGD","LU2108987350.USD","IE00B7KXQ091.USD","LU2168564495.EUR","LU0494093205.USD","LU0345770993.USD","LU0472753341.HKD","BK4532","LU0557290698.USD","LU0158827948.USD","LU2756315318.SGD","LU1400636657.SGD","LU1868837300.USD","LU0320765059.SGD","LU0267386448.USD","LU2213496289.HKD","BK4534","IE00BFSS7M15.SGD","LU1084165304.USD","LU2592432038.USD","LU0124676726.USD","LU0689626769.HKD","BK4539","SGXZ99366536.SGD","LU0289961442.SGD","LU0820561909.HKD","BK4503","LU2111349929.HKD","BK4211","IE00B19Z8X17.USD","LU1551013425.SGD","LU1983260115.SGD","LU2896262040.SGD","LU1242518857.USD","BK4567","LU0823421416.USD","LU2125909759.SGD","LU1267930730.SGD","LU0345769128.USD","LU1035775433.USD","LU0823434583.USD","LU1674673428.USD","BK4543","LU2237438978.USD","IE0004445239.USD","LU2430703251.USD","LU2602419157.SGD","IE00B775H168.HKD","IE00BJTD4V19.USD","LU0256863902.USD","LU0820561818.USD","LU2249611893.SGD","LU0061474705.USD","LU2756315664.SGD","LU0308772762.SGD","IE00BHPRN162.USD","LU0109392836.USD","IE00B4YYXB79.USD","BK4587","LU1974910355.USD"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2622823371","title":"RenovoRx Inc - Appoints Ramtin Agah as Executive Chairman Effective February 27, 2026 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2622823371","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622823371?lang=en_us&edition=fundamental","pubTime":"2026-03-27 19:03","pubTimestamp":1774609383,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260327:nFWN40F02G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","RNXT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622233108","title":"Werewolf Therapeutics FY2025 net loss narrows 13.76% to $61 million; cash and cash equivalents drop 48.6% to $57 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2622233108","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622233108?lang=en_us&edition=fundamental","pubTime":"2026-03-27 19:02","pubTimestamp":1774609321,"startTime":"0","endTime":"0","summary":"Q4 net loss was USD 8.4 million, a 58.92% narrowing, and R&D expense was USD 6.9 million, down 55.92%.G&A expense in Q4 was USD 2.5 million, down 46.23%, and cash and cash equivalents were USD 57.1 million as of Dec. 31, 2025.FY net loss was USD 60.8 million, a 13.74% narrowing, and FY R&D expense was USD 44.8 million, down 20.55%.The company said its cash position is expected to fund operating expenses and capital requirements into Q4 2026, and it engaged Piper Sandler as exclusive financial advisor for the strategic evaluation process.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260327:nNDL43myKY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LU2210150020.SGD","SG9999014021.USD","SG9999014039.USD","BK4112","LU0314104364.USD","IE00BKPKM429.USD","IE00BGHQF748.EUR","SG9999014013.SGD","IE00B3QW5Z07.USD","BK4127","IE00BN0W2W23.USD","IE00B64PRP62.GBP","LU0053671581.USD","LU2095319765.USD","BK4588","PIPR","BK4539","SG9999014005.SGD","IE00BN0W2V16.EUR","NDAQ","IE00BN0W2T93.GBP","BK4585","LU2210149790.SGD","HOWL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622982333","title":"RenovoRx appoints Ramtin Agah executive chairman; base salary rises to $450,000","url":"https://stock-news.laohu8.com/highlight/detail?id=2622982333","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622982333?lang=en_us&edition=fundamental","pubTime":"2026-03-27 19:01","pubTimestamp":1774609306,"startTime":"0","endTime":"0","summary":"RenovoRx appointed Ramtin Agah to the newly created role of Executive Chairman, effective Feb. 27, 2026.Agah also serves as the company’s Chief Medical Officer and Chairman of the Board.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. RenovoRx Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 27, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260327:nNDL7fDm62:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4539","RNXT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622982804","title":"Werewolf Therapeutics Q4 Basic EPS USD -0.17","url":"https://stock-news.laohu8.com/highlight/detail?id=2622982804","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622982804?lang=en_us&edition=fundamental","pubTime":"2026-03-27 19:00","pubTimestamp":1774609201,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260327:nPLX157F08:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HOWL","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622394823","title":"Werewolf Therapeutics Inc - Initiates Process to Explore Strategic Alternatives","url":"https://stock-news.laohu8.com/highlight/detail?id=2622394823","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622394823?lang=en_us&edition=fundamental","pubTime":"2026-03-27 19:00","pubTimestamp":1774609201,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260327:nPLX157F08:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","HOWL","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622823833","title":"Press Release: Werewolf Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2622823833","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622823833?lang=en_us&edition=fundamental","pubTime":"2026-03-27 19:00","pubTimestamp":1774609200,"startTime":"0","endTime":"0","summary":"WATERTOWN, Mass., March 27, 2026  -- Werewolf Therapeutics, Inc.  , an innovative biopharmaceutical company pioneering the development of conditionally activated therapeutics engineered to stimulate the body's immune system for the treatment of cancer and other immune-mediated conditions, today provided a business update and reported financial results for the fourth quarter and year ended December 31, 2025.\"We have initiated a process to explore a range of alternatives available to the Company to maximize stockholder value,\" said Daniel J. Hicklin, Ph.D., President and Chief Executive Officer of Werewolf. \"Such measures may include, among other options, a sale of the Company, a business combination or merger, a sale of assets, licensing or collaboration arrangements, or other strategic transactions. In addition to our clinical-stage candidates and our named earlier-stage candidates, our INDUKINE and INDUCER platforms provide exciting opportunities to apply our differentiated masking an","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4604","TM","BK4022","BK4588","BK4139","BK4555","BK4099","03160","R","BK4585","BK4232","BK4539","HOWL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622482379","title":"BioXcel Therapeutics Reports Fourth Quarter and Full-Year 2025 Financial Results as Company Prepares for Potential IGALMI® Approval in Outpatient Setting","url":"https://stock-news.laohu8.com/highlight/detail?id=2622482379","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622482379?lang=en_us&edition=fundamental","pubTime":"2026-03-27 19:00","pubTimestamp":1774609200,"startTime":"0","endTime":"0","summary":"sNDA submitted seeking approval of IGALMI in the at-home (outpatient) setting for the treatment of acute agitation associated with bipolar disorders or schizophrenia sNDA submission timeline supports ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/03/27/3263683/0/en/BioXcel-Therapeutics-Reports-Fourth-Quarter-and-Full-Year-2025-Financial-Results-as-Company-Prepares-for-Potential-IGALMI-Approval-in-Outpatient-Setting.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4139","LENZ","BK4007","ESG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622237908","title":"Autolus Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Business Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2622237908","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622237908?lang=en_us&edition=fundamental","pubTime":"2026-03-27 19:00","pubTimestamp":1774609200,"startTime":"0","endTime":"0","summary":"AUCATZYL (obecabtagene autoleucel) net product revenue of $23.3 million* for the fourth quarter of 2025 and $74.3 million* for the full year of 2025AUCATZYL UK launch underway following successful Nat","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/03/27/3263674/0/en/Autolus-Therapeutics-Reports-Fourth-Quarter-and-Full-Year-2025-Financial-Results-and-Business-Updates.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4110","IE0031619046.USD","IE00B19Z4B17.USD","ORR","BK4533","ASH","LU2065731478.USD","ALL","BK4588","BK4139","CRS","LU0963586101.USD","CAR","BK4543","IE00B66KJ199.SGD","BK4230","BK4109","BK4107","NICE","LU0985320562.USD","BK4023","LENZ","BK4539","LU2463526074.USD","BK4007","LU2355687059.USD","BK4006","IE00B7SZL793.SGD","BK4585","BK4022","LU1571399168.USD","BK4187","LU1699723380.USD","IE00BFMHRM44.USD","BK4566","ACR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622828322","title":"Otsuka to Buy Transcend Therapeutics to Deepen Push Into Next-Generation Psychiatric Drugs","url":"https://stock-news.laohu8.com/highlight/detail?id=2622828322","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622828322?lang=en_us&edition=fundamental","pubTime":"2026-03-27 18:41","pubTimestamp":1774608101,"startTime":"0","endTime":"0","summary":"An announcement from Otsuka Holdings Co ( ($JP:4578) ) is now available. Otsuka Pharmaceutical, a 100% subsidiary of Otsuka Holdings, has agreed to...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/otsuka-to-buy-transcend-therapeutics-to-deepen-push-into-next-generation-psychiatric-drugs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/otsuka-to-buy-transcend-therapeutics-to-deepen-push-into-next-generation-psychiatric-drugs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BK4539","BK4139","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622828347","title":"Citi ups Biomea Fusion target, adds ‘upside 90-day catalyst watch’","url":"https://stock-news.laohu8.com/highlight/detail?id=2622828347","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622828347?lang=en_us&edition=fundamental","pubTime":"2026-03-27 18:32","pubTimestamp":1774607553,"startTime":"0","endTime":"0","summary":"Citi raised the firm’s price target on Biomea Fusion (BMEA) to $7 from $6 and keeps a Buy rating on the shares. Citi also added an “upside 90-day c...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/citi-ups-biomea-fusion-target-adds-upside-90-day-catalyst-watch-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/citi-ups-biomea-fusion-target-adds-upside-90-day-catalyst-watch-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","BMEA","BK4139","BK4585"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":75,"pageCount":14,"totalSize":1494,"code":"91000000","status":"200"}]}}